<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02329145</url>
  </required_header>
  <id_info>
    <org_study_id>204069</org_study_id>
    <nct_id>NCT02329145</nct_id>
  </id_info>
  <brief_title>Renal Denervation in Patients With Chronic Heart Failure and Resynchronization Therapy</brief_title>
  <official_title>Renal Denervation in Patients With Chronic Heart Failure and Resynchronization Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jagiellonian University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jagiellonian University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic heart failure is becoming more and more common disease and activation of sympathetic
      nervous system plays a crucial role in its development. There is some data allowing to
      suspect that one of the new treatment methods- renal denervation, also in patients with
      chronic heart failure may lead to decrease of systemic activity sympathetic nervous system
      and, as a consequence, to decrease of disease progression. The research hypothesis is whether
      renal denervation in case of symptomatic heart failure, even the optimal treatment therapy is
      used (including resynchronization therapy), is contributing to the improvement in parameters
      of neurohormonal activation, hemodynamics and clinical patient status. The aim of the study
      is to obtain a new knowledge concerning renal denervation in chronic heart failure, So far
      only very limited data- mostly case reports- are available in this study area.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of hospitalizations due to heart failure worsening.</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in NYHA class.</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in 6 minute walk test distance.</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Active treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Renal denervation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Observational</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>renal denervation</intervention_name>
    <arm_group_label>Active treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age ≥ 18 year

          2. heart failure patients NYHA Class II - IV

          3. implanted resynchronization pacemaker according to current european guidelines at
             least 6 months earlier

          4. symptoms of heart failure even on optimal pharmacological therapy including
             resynchronization therapy (lack of improvement within dyspnoea and exercise tolerance
             after the procedure)

          5. left ventricular ejection function ≤ 35%

          6. glomerular filtration rate (eGFR according to MDRD formula ≥ 30 mL/min/1.73m2)

          7. patient informed consent for participation in the study

        Exclusion Criteria:

          1. renal artery anatomy not eligible for denervation (at least 4 mm diameter, 20 mm in
             length)

          2. history of prior renal artery intervention

          3. single functioning kidney

          4. clinic systolic BP &lt; 110mmHg

          5. pregnancy

          6. acute coronary syndrome or cerebrovascular event within last 3 months

          7. serious medical conditions which may adversely affect safety- clinically significant
             peripheral vascular disease, abdominal aortic aneurysm, bleeding disorders
             (thrombocytopenia, hemophilia, or significant anemia)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aleksander Kusiak, PhD,MD</last_name>
    <phone>+48124247300</phone>
    <email>alek.kusiak@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ist Department of Cardiology, Interventional Electrocardiology and Hypertension</name>
      <address>
        <city>Krakow</city>
        <state>Malopolska</state>
        <zip>31-501</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aleksander Kusiak, MD, PHD</last_name>
      <phone>+48124247300</phone>
      <email>alek.kusiak@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2014</study_first_submitted>
  <study_first_submitted_qc>December 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2014</study_first_posted>
  <last_update_submitted>December 29, 2014</last_update_submitted>
  <last_update_submitted_qc>December 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 31, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jagiellonian University</investigator_affiliation>
    <investigator_full_name>Aleksander Kusiak</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>renal denervation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

